Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Biotech
Sana strips back cancer, CNS programs while warning of layoffs
Sana has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases.
James Waldron
Nov 5, 2024 7:05am
IGM pivots from cancer to autoimmune, shaking up C-suite
Oct 1, 2024 7:05am
Zenas, Bicara set out to raise $180M-plus in separate IPOs
Sep 6, 2024 8:18am
Navigator raises $100M to develop new autoimmune pipeline
Aug 27, 2024 8:50am
Cue lays off 25%, prioritizing preclinical autoimmune assets
Jul 26, 2024 4:29am
J&J's phase 2 Sjögren's data support FcRn strategy
Jun 17, 2024 8:47am
